Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
The Journal of Urology|April 28, 2025
Pelvic Lymph Node Dissection in Prostate Cancer: Is It Really Necessary? A Multicentric Longitudinal Study Assessing Oncological Outcomes in Patients With Prostate Cancer Patients Undergoing Pelvic Lymph Node Dissection vs Radical Prostatectomy OnlyMarc A Furrer, Niranjan J Sathianathen, Clancy J Mulholland, et al.
Clinical and Translational Radiation Oncology|May 6, 2024
Erectile function preservation after salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: Five-year results of the SAKK 09/10 randomized phase 3 trialDaniel R Zwahlen, Christina Schröder, Lisa Holer, et al.
European Urology Oncology|August 15, 2019
Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative MorbidityAntoni Vilaseca, Giuliano Guglielmetti, Emily A Vertosick, et al.
European Urology|October 11, 2014
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)Nicholas David James, Melissa R Spears, Noel W Clarke, et al.
The Journal of Urology|January 25, 2017
Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter StudyPadraic G O'Malley, Daniel P Nguyen, Bashir Al Hussein Al Awamlh, et al.
European Urology|November 18, 2021
Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational TrialAbdullatif Aydın, Kamran Ahmed, Takashige Abe, et al.
Nature Communications|February 19, 2021
Patient-derived xenografts and organoids model therapy response in prostate cancerSofia Karkampouna, Federico La Manna, Andrej Benjak, et al.
The Journal of Urology|January 9, 2018
Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?Daniel P Nguyen, Emily A Vertosick, Vidit Sharma, et al.
World Journal of Urology|May 20, 2022
Morbidity of salvage radical prostatectomy: limited impact of the minimally invasive approachMarlon Perera, Antoni Vilaseca, Amy L Tin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Ewan A Gibb, Natalie Q Wang, et al.
Pageof 26